Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 561

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 561
---
 to Consolidated Financial Statements Note 6 — Commitments and Contingencies (cont.) The Business Combination is subject to customary closing conditions, including the satisfaction of the minimum available cash condition of $ 15,000,000, the receipt of certain governmental approvals and the required approval by the stockholders of NorthView and Profusa. There is no assurance that the Business Combination will be completed. The aggregate consideration to be received by the Profusa shareholders is based on a pre -transactionequity value of $ 155,000,000. The exchange ratio will be equal to (a) $ 155,000,000, divided by an assumed value of NorthView Common Stock of $ 10.00per share. Subject to certain future revenue and stock -pricebased milestones, Profusa shareholders will have the right to receive an aggregate of up to an additional 3,875,000shares of NorthView Common Stock. On September 12, 2023, the parties to the Merger Agreement entered into Amendment No. 1 to the Merger Agreement (the “Amendment”) pursuant to which the parties agreed to revise the revenue earnout milestones to reflect updated projections provided by Profusa. Specifically, Amendment No. 1 revised the definition of “Milestone Event III” and “Milestone Event IV” such that one -quarterof the Earnout Shares would be issued to Profusa stockholders if the combined company achieves Earnout Revenue of $ 11,864,000for the fiscal year ended December 31, 2024, and one -quarterof the Earnout Shares would be issued to Profusa stockholders if the combined company achieves Earnout Revenue of $ 99,702,000for the fiscal year ended December 31, 2025. Amendment No. 1 also clarified the exercise price of certain of the Company’s Warrants. On September 14, 2023 and September 29, 2023, the Company paid Profusa related expenses in the amount of $ 25,000, respectively, for a total of $ 50,000. The Profusa related expenses will not be repaid and are reflected in operating costs in the Company’s consolidated statement of operations. Note 7 — Stockholders’ Deficit Preferred stock— The Company is authorized to issue 1,000,000shares of preferred stock with a par value of $ 0.0001and with such designations, rights and preferences as may be determined from time to time by the Company’s board of